InvestorsHub Logo
Followers 29
Posts 1201
Boards Moderated 0
Alias Born 12/29/2018

Re: None

Thursday, 09/03/2020 2:42:52 PM

Thursday, September 03, 2020 2:42:52 PM

Post# of 424639
From ST


AMRN needs to go to Teva and workout a buyout deal... Why this would be good.. A.)Teva is a generics monster and will mop the floor with those penny-ante Generics like Dr. Buttheads and Hikima in the USA and beat them at their own game .B.) Teva has a heavy presence in Europe and will be able to sell the crap out of Vascepa there. They win on both ends. $20 a share gets it done
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News